Eurofins expands into hygiene testing in hospitals with the acquisition of Biotech-Germande

Eurofins Scientific (EUFI.PA), the global leader in bioanalytical testing of food, pharmaceuticals and the environment, announces that it has signed an agreement to acquire Biotech-Germande SAS (BG), one of the leading players in the environmental clinical testing and hospital hygiene market, as well as in medical device evaluation in France.

Located in Marseille, BG employs 40 staff, and has established a strong reputation over the last 15 years, as a reference in healthcare and hospital hygiene. The company conducts testing of water, air, surfaces and endoscopes in hospitals and healthcare facilities, as well as evaluation of medical devices for manufacturers. BG has seen, and expects to continue to post, strong growth driven primarily by hospitals outsourcing mandatory infectious controls, and increasingly stringent regulations for independent testing of medical devices.

The acquisition complements Eurofins' growing footprint in the testing market for the healthcare sector in France, and allows the Group to create a more compelling portfolio of services for hospitals and other healthcare facilities served by Bioaccess and Biomnis. In return, BG should gain access to Eurofins' infrastructure, including the Group's complete testing portfolio for hospitals and drug & medical device manufacturers, and could leverage Eurofins' extensive network to further accelerate growth. Eurofins' existing footprint in water testing, as well as the Group's unparalleled capabilities in microbiology, should allow BG to expand its market reach or accelerate share gains in its existing markets.

Comment from Dr. Gilles Martin, Eurofins CEO: "Biotech-Germande strengthens Eurofins' service offering to hospitals in a key area for patients' safety, and reinforces our growing footprint in medical device testing. We look forward to strengthening BG's position in its market by providing them access to the Group's complete range of capabilities, as well as client base."